Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 3/20 | 0.35 |
| ▸ | PTGES | O14684 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MPI | P34949 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21717407 | 1.00 | TSPO (0.38) | TSPOHTR6PTGESKDM4EHSD17B10 | |
| SCHEMBL21718109 | 0.97 | TSPO (0.36) | TSPOHTR6PTGESKDM4EHSD17B10 | |
| SCHEMBL21718108 | 0.97 | TSPO (0.36) | TSPOHTR6PTGESKDM4EHSD17B10 | |
| SCHEMBL22858283 | 0.94 | TSPO (0.40) | TSPOHTR6PTGESKDM4EHSD17B10 | |
| SCHEMBL21717382 | 0.94 | TSPO (0.40) | TSPOHTR6PTGESKDM4EHSD17B10 | |
| SCHEMBL21717839 | 0.92 | ESR1 (0.38) | TSPOHTR6PTGESKDM4EHSD17B10 | |
| SCHEMBL21717832 | 0.92 | TSPO (0.39) | TSPOHTR6PTGESKDM4EHSD17B10 | |
| SCHEMBL22679275 | 0.92 | TSPO (0.39) | TSPOHTR6PTGESKDM4EHSD17B10 | |
| SCHEMBL21710664 | 0.91 | PTGES (0.32) | TSPOPTGESHSD17B10NPY5RALDH1A1 | |
| SCHEMBL22679811 | 0.90 | KDM4E (0.36) | TSPOHTR6PTGESKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20200365812-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-11-19 | — | — | US | disclosed |
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | LEF1, L1CAM, ESR2 | TSPO 1263/4885HTR6 4744/4885PTGES 2858/4885 |
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | EML4, EBPL, LEF1 | TSPO 789/4885HTR6 4071/4885PTGES 4447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.